Chris Viehbacher News
Most Popular Chris Viehbacher Story
Sanofi CEO challenges FDA to clear up regulatory pathway for new meds
Drug developers have had it with FDA reviews of new meds for major diseases such as diabetes and obesity. U.S. regulators have shot down or stalled a slew of applications for such drugs because of Read more...
Latest Headlines
- February 8, 2012
- February 6, 2012
- January 17, 2012
- January 11, 2012
- September 6, 2011
- February 10, 2011
- February 10, 2011
- December 23, 2010
- November 8, 2010
- October 8, 2010
- October 4, 2010
- September 30, 2010
- September 9, 2010
- July 30, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
